Work

A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.3599

Authors: Federico Innocenti, Kouros Owzar, Chen Jiang, Alexander Sibley, Donna Niedzwiecki, Heinz-Josef Lenz, Monica M. Bertagnolli, Paula N. Friedman, Yoichi Furukawa, Michiaki Kubo, Mark J. Ratain, Charles David Blanke, Alan P. Venook, Howard L. McLeod

Institutions: University of North Carolina at Chapel Hill, Duke University, Duke Medical Center, Duke Cancer Institute, USC Norris Comprehensive Cancer Center, Brigham and Women's Hospital, University of Chicago, Institute of Medical Science, The University of Tokyo, The University of Tokyo, RIKEN, Oregon Health & Science University, University of California, San Francisco, Moffitt Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599224646

Cites:

Cited by: 1

Related to: 10